IMPROVED SURVIVAL WITH IPILIMUMAB IN PATIENTS WITH ADVANCED MELANOMA IN REAL-WORLD CLINICAL PRACTICE: FIRST RESULTS OF THE DUTCH MELANOMA TREATMENT REGISTRY

被引：1
|
作者：
Leeneman, B. [1 ]
Franken, M. G. [2 ]
Jochems, A. [3 ]
Schouwenburg, M. G. [4 ]
Wouters, M. W. [5 ]
Van den Eertwegh, A. J. [6 ]
Haanen, J. B. [5 ]
Van der Hoeven, K. J. [3 ]
Uyl-de Groot, C. A. [2 ]
机构：
[1] Erasmus Univ, Inst Med Technol Assessment, Rotterdam, Netherlands
[2] Erasmus Univ, Rotterdam, Netherlands
[3] Leiden Univ, Med Ctr, Leiden, Netherlands
[4] Dutch Inst Clin Auditing, Deventer, Netherlands
[5] Netherlands Canc Inst, Amsterdam, Netherlands
[6] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN62
引用
收藏
页码：A440 / A440
页数：1
相关论文
共 50 条
  • [31] Real-world outcomes of advanced melanoma patients not represented in phaseIIItrials
    van Zeijl, Michiel C. T.
    Ismail, Rawa K.
    de Wreede, Liesbeth C.
    van den Eertwegh, Alfonsus J. M.
    de Boer, Anthonius
    van Dartel, Maaike
    Hilarius, Doranne L.
    Aarts, Maureen J. B.
    van den Berkmortel, Franchette W. P. J.
    Boers-Sonderen, Marye J.
    de Groot, Jan-Willem B.
    Hospers, Geke A. P.
    Kapiteijn, Ellen
    Piersma, Djura
    van Rijn, Rozemarijn S.
    Suijkerbuijk, Karijn P. M.
    ten Tije, Albert J.
    van der Veldt, Astrid A. M.
    Vreugdenhil, Gerard
    Haanen, John B. A. G.
    Wouters, Michel W. J. M.
    INTERNATIONAL JOURNAL OF CANCER, 2020, 147 (12) : 3461 - 3470
  • [32] Ipilimumab for advanced melanoma in the real world: The Northern Ireland experience
    Gallagher, P. F.
    Stewart, J.
    Carser, J. E.
    McAleer, J. J.
    Coyle, V.
    Oladipo, O.
    ANNALS OF ONCOLOGY, 2017, 28
  • [33] Real Life Clinical Management and Survival in Advanced Cutaneous Melanoma: The Italian Clinical National Melanoma Registry Experience
    Crispo, Anna
    Corradin, Maria Teresa
    Giulioni, Erika
    Vecchiato, Antonella
    Del Fiore, Paolo
    Queirolo, Paola
    Spagnolo, Francesco
    Vanella, Vito
    Caraco, Corrado
    Tosti, Giulio
    Pennacchioli, Elisabetta
    Giudice, Giuseppe
    Nacchiero, Eleonora
    Quaglino, Pietro
    Ribero, Simone
    Giordano, Monica
    Marussi, Desire
    Barruscotti, Stefania
    Guida, Michele
    De Giorgi, Vincenzo
    Occelli, Marcella
    Grosso, Federica
    Cairo, Giuseppe
    Gatti, Alessandro
    Massa, Daniela
    Atzori, Laura
    Calvani, Nicola
    Fabrizio, Tommaso
    Mastrangelo, Giuseppe
    Toffolutti, Federica
    Celentano, Egidio
    Budroni, Mario
    Gandini, Sara
    Rossi, Carlo Riccardo
    Testori, Alessandro
    Palmieri, Giuseppe
    Ascierto, Paolo A.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [34] COMPARABILITY OF OVERALL SURVIVAL IN REAL-WORLD AND CLINICAL TRIAL DATA FOR BRAF plus ADVANCED MELANOMA
    Sajeev, G.
    Chen, K.
    In, G.
    Simpson, R.
    Kalia, S.
    Christensen, D.
    Liu, D.
    Rezai, N.
    di Pietro, A.
    Signorovitch, J.
    VALUE IN HEALTH, 2023, 26 (12) : S12 - S12
  • [35] Long-term survival of real-world advanced melanoma patients treated with targeted therapy
    Ismail, R.
    de Boer, A.
    van Dartel, M.
    Hilarius, D.
    van Zeijl, M.
    van den Eertwegh, F.
    Aarts, M.
    Van den Berkmortel, F.
    Boers-Sonderen, M.
    de Groot, J. W. B.
    Haanen, J. B. A. G.
    Hospers, G. A. P.
    Kapiteijn, E.
    Piersma, D.
    van Rijn, R.
    Suijkerbuijk, K. P. M.
    ten Tije, A. J.
    Van der Veldt, A. A. M.
    Vreugdenhil, G.
    Wouters, M.
    ANNALS OF ONCOLOGY, 2020, 31 : S745 - S746
  • [36] Clinical predictors of survival in real world practice in stage IV melanoma
    Hu, Hsien-Pang
    Archer, Christine
    Yip, Desmond
    Peters, Geoffrey
    CANCER REPORTS, 2023, 6 (02)
  • [37] Clinical predictors of survival in real world practice in stage IV melanoma
    Hu, Hsien-Pang
    Archer, Christine
    Yip, Desmond
    Peters, Geoffrey
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 181 - 182
  • [38] Real-world outcomes with immuno-oncology therapies in advanced melanoma: final results of the OPTIMIzE registry study
    Kirkwood, John M.
    Kottschade, Lisa A.
    McWilliams, Robert R.
    Khushalani, Nikhil, I
    Jang, Sekwon
    Hallmeyer, Sigrun
    McDermott, David F.
    Tawbi, Hussein
    Che, Min
    Lee, Cho-Han
    Ritchings, Corey
    Le, Trong Kim
    Park, Boas
    Ramsey, Scott
    IMMUNOTHERAPY, 2024, 16 (01) : 29 - 42
  • [39] Real-world overall survival in advanced melanoma from the IMAGE study.
    Middleton, Mark R.
    Corne, Philippa
    Dalle, Stephane
    Lotem, Michal
    Board, Ruth
    Fernandez, Ana Maria Arance
    Meiss, Frank
    Terheyden, Patrick
    Gutzmer, Ralf
    Loquai, Carmen
    Talbot, Toby
    Herbst, Rudolf
    Kaehler, Katharina C.
    Kotapati, Srividya
    Le, Trong Kim
    Abernethy, Amy Pickar
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [40] Outcomes for systemic therapy in older patients with metastatic melanoma: Results from the Dutch Melanoma Treatment Registry
    Jochems, Anouk
    Bastiaannet, Esther
    Aarts, Maureen J. B.
    van Akkooi, Alexander C. J.
    van den Berkmortel, Franchette W. P. J.
    Boers-Sonderen, Marye J.
    van den Eertwegh, Alfonsus J. M.
    de Glas, Nienke G.
    de Groot, Jan Willem B.
    Haanen, John B. A. G.
    Hospers, Geke A. P.
    van der Hoeven, Jacobus J. M.
    Piersma, Djura
    van Rijn, Rozemarijn S.
    Suijkerbuijk, Karijn P. M.
    ten Tije, Albert J.
    van der Veldt, Astrid A. M.
    Vreugdenhil, Gerard
    van Zeijl, Michiel C. T.
    Kapiteijn, Ellen
    Wouters, Michel W. J. M.
    JOURNAL OF GERIATRIC ONCOLOGY, 2021, 12 (07) : 1031 - 1038
12345